<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02376387</url>
  </required_header>
  <id_info>
    <org_study_id>NIH 41169</org_study_id>
    <nct_id>NCT02376387</nct_id>
  </id_info>
  <brief_title>Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation</brief_title>
  <acronym>DHS</acronym>
  <official_title>Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>California Transplant Donor Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Donor Network of Arizona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gift of Life</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gift of Hope</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lifelink Healthcare Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New England Organ Bank</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Life Gift Organ Donation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed research will provide evidence-based strategies for the evaluation and
      acceptance of donor hearts for transplantation. This is relevant to public health because
      judicious expansion of donor hearts used for transplantation will make this life-saving
      procedure available to a larger number of patients living with end-stage heart disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The demand for donor hearts for transplantation far outstrips the supply; however, only one
      in three available cardiac grafts are used for transplantation. There are many reasons for
      graft non-use, but previous studies have failed to demonstrate consistent associations
      between donor characteristics, donor cardiac function, and adverse recipient outcomes. Thus,
      there is a critical need to standardize how cardiac allografts are evaluated and accepted for
      transplantation. The investigators long-term goal is to safely expand the use of available
      cardiac allografts without adversely affecting transplant recipient outcomes. The
      investigators propose to carefully characterize the current population of cardiac organ
      donors, particularly with regards to allograft function; to examine how decisions are made
      regarding graft acceptance for transplantation; and to systematically evaluate associations
      between donor characteristics and recipient outcomes. The investigators central hypothesis is
      that acceptable allografts for heart transplantation are being unnecessarily discarded, and
      the establishment of an evidence-based process for cardiac donor evaluation and acceptance
      will increase graft utilization rates while maintaining excellent clinical outcomes. In
      response to this need, the investigators propose a collaborative study with seven organ
      procurement organizations representing geographically diverse regions of the United States,
      to address the following specific aims: (1) To identify clinical correlates of graft function
      in potential donors being evaluated for heart transplantation. An existing online donor
      research database will be expanded for standardized collection of data on detailed donor
      characteristics, especially as pertains to cardiac allograft function. The investigators will
      perform expert core review of donor echocardiograms, including serial echocardiograms in
      donors with cardiac allograft dysfunction. Serial electrocardiograms and cardiac biomarkers
      (Troponin I and B-type natriuretic peptide) will also be studied; (2) To prospectively study
      reasons for cardiac allograft non-utilization for heart transplantation. Real-time data will
      be collected on specific reasons for allograft non-acceptance for transplantation in order to
      study graft acceptance practices and variation in graft utilization nationwide; and (3) To
      prospectively study associations between donor characteristics and recipient outcomes after
      heart transplantation. Data will be collected on recipient post-transplant length of
      hospitalization and survival to identify associations between donor predictors and recipient
      outcomes. This proposal is innovative because it focuses on an entirely different approach to
      donor-based research, thereby surmounting the limitations of prior investigations. Completion
      of the proposed study will have a positive impact by defining how to optimize the evaluation
      and use of available grafts for heart transplantation, thereby safely expanding the donor
      pool and increasing the number of heart transplants performed nationwide.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Donor left ventricular ejection fraction, troponin, BNP, EKG changes (arrhythmias, QT prolongation, repolarization abnormalities, LVH, Q waves)</measure>
    <time_frame>5 years</time_frame>
    <description>To identify clinical correlates of cardiac function in potential donors being evaluated for heart transplantation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify decline codes for donor hearts not accepted for transplant</measure>
    <time_frame>5 years</time_frame>
    <description>To prospectively study reasons for non-acceptance of hearts offered for transplantation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Create a statistical tools (e.g. risk prediction model) for donor heart acceptance</measure>
    <time_frame>5 years</time_frame>
    <description>To develop clinical tools to assist transplant centers with real-time decisions regarding donor heart acceptance.</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Heart Transplantation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Brain dead donors for heart transplant
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Brain dead (beating heart)

          2. 18-65 years of age

          3. HIV (-)

          4. Donors authorized for research

        Exclusion Criteria:

          1. Donors not authorized for research

          2. HIV (+)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Donor Network of Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Transplant Donor Network</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LifeLink</name>
      <address>
        <city>Norcross</city>
        <state>Georgia</state>
        <zip>30071</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gift of Hope</name>
      <address>
        <city>Itasca</city>
        <state>Illinois</state>
        <zip>60143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New England Organ Bank</name>
      <address>
        <city>Waltham</city>
        <state>Massachusetts</state>
        <zip>02451</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gift of Life</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LifeGift</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Khush KK, Menza R, Nguyen J, Zaroff JG, Goldstein BA. Donor predictors of allograft use and recipient outcomes after heart transplantation. Circ Heart Fail. 2013 Mar;6(2):300-9. doi: 10.1161/CIRCHEARTFAILURE.112.000165. Epub 2013 Feb 7.</citation>
    <PMID>23392789</PMID>
  </reference>
  <reference>
    <citation>Shah MR, Starling RC, Schwartz Longacre L, Mehra MR; Working Group Participants. Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group. J Am Coll Cardiol. 2012 Apr 3;59(14):1263-9. doi: 10.1016/j.jacc.2011.11.050. Review.</citation>
    <PMID>22464255</PMID>
  </reference>
  <reference>
    <citation>Chen JM, Sinha P, Rajasinghe HA, Suratwala SJ, McCue JD, McCarty MJ, Caliste X, Hauff HM, John R, Edwards NM. Do donor characteristics really matter? Short- and long-term impact of donor characteristics on recipient survival, 1995-1999. J Heart Lung Transplant. 2002 May;21(5):608-10.</citation>
    <PMID>11983553</PMID>
  </reference>
  <reference>
    <citation>De La Zerda DJ, Cohen O, Beygui RE, Kobashigawa J, Hekmat D, Laks H. Alcohol use in donors is a protective factor on recipients' outcome after heart transplantation. Transplantation. 2007 May 15;83(9):1214-8.</citation>
    <PMID>17496538</PMID>
  </reference>
  <reference>
    <citation>Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006 Jul 4;114(1 Suppl):I27-32.</citation>
    <PMID>16820584</PMID>
  </reference>
  <reference>
    <citation>Nixon JL, Kfoury AG, Brunisholz K, Horne BD, Myrick C, Miller DV, Budge D, Bader F, Everitt M, Saidi A, Stehlik J, Schmidt TC, Alharethi R. Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation. Clin Transplant. 2012 Mar-Apr;26(2):322-7. doi: 10.1111/j.1399-0012.2011.01504.x. Epub 2011 Oct 10.</citation>
    <PMID>21981698</PMID>
  </reference>
  <reference>
    <citation>Patel ND, Weiss ES, Nwakanma LU, Russell SD, Baumgartner WA, Shah AS, Conte JV. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. Circulation. 2008 Sep 30;118(14 Suppl):S83-8. doi: 10.1161/CIRCULATIONAHA.107.756866.</citation>
    <PMID>18824775</PMID>
  </reference>
  <reference>
    <citation>Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, Zuckermann A. Donor scoring system for heart transplantation and the impact on patient survival. J Heart Lung Transplant. 2012 Apr;31(4):387-97. doi: 10.1016/j.healun.2011.11.005. Epub 2011 Dec 16.</citation>
    <PMID>22177692</PMID>
  </reference>
  <reference>
    <citation>Weiss ES, Allen JG, Kilic A, Russell SD, Baumgartner WA, Conte JV, Shah AS. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. J Heart Lung Transplant. 2012 Mar;31(3):266-73. doi: 10.1016/j.healun.2011.10.004. Epub 2011 Nov 16.</citation>
    <PMID>22093382</PMID>
  </reference>
  <reference>
    <citation>Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J. Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant. 2011 Dec;11(12):2755-61. doi: 10.1111/j.1600-6143.2011.03744.x. Epub 2011 Sep 11.</citation>
    <PMID>21906259</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>February 24, 2015</last_update_submitted>
  <last_update_submitted_qc>February 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Kiran Khush</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

